Sign In
Buy CRLBF
$0.770
-0.0401 (-4.95%)
At Close: Jun 22, 2026
Top Cannabis Companies Building Momentum in June 2026
10:00am, Tuesday, 16'th Jun 2026
The cannabis industry continues to evolve across the United States. Several operators are expanding their retail footprints while improving profitability. At the same time, investors are watching for
Cannabis Operator Cresco Down 28.5% YTD: How to Play the Stock?
09:16am, Thursday, 11'th Jun 2026
CRLBF is down 28.5% YTD as revenue pressure and competition persist, but retail expansion and improving estimates could shape its next move.
Cresco Labs Closes US$50 Million Revolving Credit Facility with Needham Bank
06:00am, Monday, 08'th Jun 2026
CHICAGO--(BUSINESS WIRE)--Access to commercial bank financing enhances financial flexibility and supports Cresco Labs' disciplined growth and consolidation strategy.
Cresco Labs Marks Historic Step Forward with Medical Cannabis Facility DEA Registration
06:30am, Wednesday, 27'th May 2026
CHICAGO--(BUSINESS WIRE)--Cresco Labs Inc. (CSE: CL) (OTCQX: CRLBF) (FSE: 6CQ) (“Cresco Labs” or the “Company”), the industry leader in branded cannabis products with a portfolio of America's
Cresco Labs Inc. (CRLBF) Upgraded to Buy: Here's Why
01:01pm, Monday, 11'th May 2026
Cresco Labs Inc. (CRLBF) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Cresco Labs Provides Update on Texas License Previously Awarded by Texas Department of Public Safety
06:30am, Monday, 11'th May 2026
CHICAGO--(BUSINESS WIRE)--Cresco Labs Inc. (CSE: CL) (OTCQX: CRLBF) (FSE: 6CQ) (“Cresco Labs” or the “Company”), today provided an update on its application under the Texas Compassionate Use P
Cresco Labs Inc. (CRLBF) Q1 2026 Earnings Call Transcript
12:31pm, Friday, 08'th May 2026
Cresco Labs Inc. (CRLBF) Q1 2026 Earnings Call Transcript
Cresco Labs Inc. (CRLBF) Reports Q1 Loss, Beats Revenue Estimates
09:05am, Friday, 08'th May 2026
Cresco Labs Inc. (CRLBF) came out with a quarterly loss of $0.04 per share versus the Zacks Consensus Estimate of a loss of $0.03. This compares to a loss of $0.04 per share a year ago.
Cresco Labs Reports First Quarter 2026 Financial Results, Advances Multiple Growth Initiatives
06:30am, Friday, 08'th May 2026
CHICAGO--(BUSINESS WIRE)--Cresco Labs Reports First Quarter 2026 Financial Results.
Why Fast-paced Mover Cresco Labs Inc. (CRLBF) Is a Great Choice for Value Investors
09:55am, Wednesday, 06'th May 2026
Cresco Labs Inc. (CRLBF) could be a great choice for investors looking to buy stocks that have gained strong momentum recently but are still trading at reasonable prices. It is one of the several stoc
Cresco Labs Opens Sunnyside Aberdeen, Marking Second Ohio Dispensary Opening in a Month
06:30am, Tuesday, 05'th May 2026
CHICAGO--(BUSINESS WIRE)--Cresco Labs Inc. (CSE: CL) (OTCQX: CRLBF) (FSE: 6CQ) (“Cresco Labs” or the “Company”), today announced the grand opening of Sunnyside Aberdeen, located in Aberdeen, O
Top Marijuana Stocks and Investment Outlook 2026
01:20pm, Monday, 04'th May 2026
The cannabis industry in the United States is entering a new phase of sustained growth, positioning itself as one of the most closely watched emerging sectors for both investors and industry professio
Marijuana Stocks: Industry Growth, Rescheduling Impact, and Outlook
12:04pm, Wednesday, 29'th Apr 2026
The cannabis industry has become one of the most closely watched emerging sectors in global finance. As a result, marijuana stocks are attracting growing attention from both retail and institutional i
The Cannabis Sector's Billion-Dollar Tax Cut
02:40pm, Thursday, 23'rd Apr 2026
On the heels of the executive order to fast-track research into psychedelic drugs, a second major federal policy shift on April 23, 2026, is sending waves through the cannabis sector. However, the rea
Cresco Labs CEO: Rescheduling Ushers in a New Era of Care for Medical Cannabis Patients
01:24pm, Thursday, 23'rd Apr 2026
CHICAGO--(BUSINESS WIRE)--Cresco Labs Inc. (CSE: CL) (OTCQX: CRLBF) (FSE: 6CQ) (“Cresco Labs” or the “Company”), today issued a statement on behalf of Cresco Labs CEO Charlie Bachtell in respo
